Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
48,592,930
-
Share change
-
+5,718,421
-
Total reported value
-
$346,980,385
-
Put/Call ratio
-
74%
-
Price per share
-
$7.14
-
Number of holders
-
103
-
Value change
-
+$42,436,397
-
Number of buys
-
62
-
Number of sells
-
49
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) as of Q3 2014
As of 30 Sep 2014,
SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,592,930 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, Visium Asset Management, LP, Citadel Advisors LLC, EAGLE ASSET MANAGEMENT INC, VANGUARD GROUP INC, Lamond Capital Partners LLC, FRANKLIN RESOURCES INC, and ORBIMED ADVISORS LLC.
This page lists
103
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.